secwatch.observer — SEC 8-K summary
======================================

Issuer:     Black Hawk Acquisition Corp (BKHA)
CIK:        0002000775
Form:       8-K
Filed at:   2025-04-29T23:59:59+00:00
Accession:  0001829126-25-003009
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Black Hawk SPAC enters $70M merger with Vesicor Therapeutics; p53 cancer therapy focus
--------------------------------------------------------------------------------

- Total equity value $70M; Aggregate Merger Consideration = $70M divided by Redemption Price.
- Vesicor must secure at least $10M in PIPE financing as condition to close.
- Post-merger CEO: Luo Feng, CFO: Michael Bowen, COO: Warren Hosseinion Jr.; 5-member board.
- Lock-up: 6 months for PubCo shares, 12 months for Vesicor warrant holders.
- Break-up fee of $1M payable by breaching party; termination rights for failure to secure PIPE or deliver audited financials by June 10, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2000775/000182912625003009/0001829126-25-003009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2000775/000182912625003009/blackhawk_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-003009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer